What is LOPJLB’s current signal on CRDF?

LOPJLB’s latest quantitative signal on Cardiff Oncology, Inc. (CRDF) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is CRDF in?

Cardiff Oncology, Inc. (CRDF) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Cardiff Oncology, Inc. (CRDF) do?

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials …

Where is Cardiff Oncology, Inc. based / listed?

Cardiff Oncology, Inc. is based in US, listed on NASDAQ.

Cardiff Oncology, Inc. (CRDF) Stock · BUY · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $66M
Avg volume: 1.3M
Short % float: 18.49%

Days to cover: 9.3
SI change: +0.9%

1W: +11.11%
1M: +20.48%
3M: -43.82%
YTD: -62.41%

vs SPY 1W: +12.30%
vs SPY 1M: +17.16%
vs SPY 3M: -46.21%
vs SPY YTD: -74.16%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Cardiff Oncology, Inc. (CRDF)

Key stats

Sector peers

Prediction markets

Company news

Congress trades

Congress trades